Company Filing History:
Years Active: 2020
Title: Gert Fricker: Innovator in Liposomal Drug Delivery
Introduction
Gert Fricker is a notable inventor based in Dossenheim, Germany. He has made significant contributions to the field of drug delivery systems, particularly through his innovative work on liposomal formulations. With a total of 2 patents, Fricker's inventions focus on enhancing the efficacy of therapeutic agents.
Latest Patents
Fricker's latest patents include groundbreaking advancements in liposomal compositions. The first patent, titled "Liposomal formulation for the oral hepatic delivery of drugs," relates to liposomal compositions that incorporate tetraether lipids (TELs) and the lipopeptide Myr-HBVpreS/2-48 (Myrcludex B). This invention aims to improve the prevention and treatment of hepatic disorders through oral delivery methods. The second patent, "Liposomes containing cell penetrating peptides and tetraetherlipids for the oral delivery of macromolecules," focuses on liposomal compositions that combine TELs and cell penetrating peptides (CPPs). This innovation also targets the oral delivery of therapeutic and diagnostic agents.
Career Highlights
Throughout his career, Gert Fricker has worked with prestigious institutions, including the University of Heidelberg and Heideltec GmbH. His work in these organizations has allowed him to develop and refine his innovative ideas in drug delivery systems.
Collaborations
Fricker has collaborated with notable colleagues, including Walter Mier and Philipp Uhl. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Gert Fricker's contributions to liposomal drug delivery represent a significant advancement in the field of pharmaceuticals. His innovative patents and collaborations highlight his commitment to improving therapeutic delivery methods.